Innovent

gold coins and bars
Biotech

Takeda strikes Innovent pact worth up to $11.4B

The deal, which includes $10.2 billion in milestones, puts the biologics at the center of Takeda’s efforts to establish new growth drivers.
Nick Paul Taylor Oct 22, 2025 9:15am
blocks stack target climb build arrow meet

Awaiting regulator verdict, Innovent posts latest psoriasis win

Oct 29, 2024 9:50am
Graphic image of an arrow nailing the bullseye of a target

Innovent bags another phase 3 win for next-gen Lilly GLP-1 drug

Jul 22, 2024 5:31am
skin cells epidermis layers lotion serum

Innovent looks to Chinese regulators after ph. 3 psoriasis win

May 28, 2024 7:55am
On target clinical trial success bullseye score

Lilly's next-gen obesity drug brings Innovent ph. 3 diabetes win

May 9, 2024 7:20am
hawaii parasail ocean

BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders

May 3, 2024 8:30am